Quidel and its subsidiaries are currently working on the development of 68 products that fall under the In Vitro Diagnostics markets. GlobalData’s report Quidel Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are either in the late stage of development or are in an early development stage.
The main research and development focus of Quidel is on infectious diseases, followed by cardiovascular diseases, women's health, immune system diseases, ophthalmic diseases, respiratory tract diseases, chemically-induced disorders, digestive system diseases, hematologic diseases and hormonal disorders.
Quidel: Top therapeutic area(s) by pipeline products
For a complete picture of the developmental pipeline for Quidel medical devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.